Marie Lamy with Asia Pacific Leaders Malaria Alliance discusses how one country is tackling drug resistance in order to eradicate Malaria.
You might also like...
// February 19, 2025
India and the United States manufacture most finished medicines for the U.S. market...
Natural disasters, trade wars and pandemics are just some of the disruptions that the U.S. pharmaceutical supply chain has faced in recent years. Identifying where drug products are made is a first step in characterizing the risk associated with these events. Learn more.
// December 19, 2024
Manufacturing pharmaceutical ingredients in Nigeria...
Poor-quality medical products are all too common in Africa, where substandard and falsified medicines kill nearly 500,000 people each year, according to the United Nations. The continent also has the highest prevalence of poor-quality medicines among low- and middle-income countries at 18.7 percent.
In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC), the national regulating authority for medical products, is prioritizing local production of medicines to ensure a safer supply of quality-assured medical products to protect patients and communities across the country and continent.
// July 02, 2024
Reflecting on results from four years fighting TB in the Kyrgyz Republic ...
In 2022, more than 8,000 people in the Kyrgyz Republic developed tuberculosis (TB), including
